204 related articles for article (PubMed ID: 21398220)
1. Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.
Chan G; Cheung LS; Yang W; Milyavsky M; Sanders AD; Gu S; Hong WX; Liu AX; Wang X; Barbara M; Sharma T; Gavin J; Kutok JL; Iscove NN; Shannon KM; Dick JE; Neel BG; Braun BS
Blood; 2011 Apr; 117(16):4253-61. PubMed ID: 21398220
[TBL] [Abstract][Full Text] [Related]
2. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
Zhu HH; Ji K; Alderson N; He Z; Li S; Liu W; Zhang DE; Li L; Feng GS
Blood; 2011 May; 117(20):5350-61. PubMed ID: 21450902
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
[TBL] [Abstract][Full Text] [Related]
4. Leukemogenic Ptpn11 allele causes defective erythropoiesis in mice.
Usenko T; Chan G; Torlakovic E; Klingmüller U; Neel BG
PLoS One; 2014; 9(10):e109682. PubMed ID: 25289670
[TBL] [Abstract][Full Text] [Related]
5. Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival.
Yang Z; Li Y; Yin F; Chan RJ
Exp Hematol; 2008 Oct; 36(10):1285-96. PubMed ID: 18640765
[TBL] [Abstract][Full Text] [Related]
6. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells.
Xu D; Liu X; Yu WM; Meyerson HJ; Guo C; Gerson SL; Qu CK
J Exp Med; 2011 Sep; 208(10):1977-88. PubMed ID: 21930766
[TBL] [Abstract][Full Text] [Related]
7. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
Xu D; Wang S; Yu WM; Chan G; Araki T; Bunting KD; Neel BG; Qu CK
Blood; 2010 Nov; 116(18):3611-21. PubMed ID: 20651068
[TBL] [Abstract][Full Text] [Related]
8. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.
Dong L; Yu WM; Zheng H; Loh ML; Bunting ST; Pauly M; Huang G; Zhou M; Broxmeyer HE; Scadden DT; Qu CK
Nature; 2016 Nov; 539(7628):304-308. PubMed ID: 27783593
[TBL] [Abstract][Full Text] [Related]
9. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase.
Ruess DA; Heynen GJ; Ciecielski KJ; Ai J; Berninger A; Kabacaoglu D; Görgülü K; Dantes Z; Wörmann SM; Diakopoulos KN; Karpathaki AF; Kowalska M; Kaya-Aksoy E; Song L; van der Laan EAZ; López-Alberca MP; Nazaré M; Reichert M; Saur D; Erkan MM; Hopt UT; Sainz B; Birchmeier W; Schmid RM; Lesina M; Algül H
Nat Med; 2018 Jul; 24(7):954-960. PubMed ID: 29808009
[TBL] [Abstract][Full Text] [Related]
10. Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.
Yang Z; Kondo T; Voorhorst CS; Nabinger SC; Ndong L; Yin F; Chan EM; Yu M; Würstlin O; Kratz CP; Niemeyer CM; Flotho C; Hashino E; Chan RJ
Mol Cell Biol; 2009 Aug; 29(16):4376-93. PubMed ID: 19528235
[TBL] [Abstract][Full Text] [Related]
11. Kit and Scl regulation of hematopoietic stem cells.
Rojas-Sutterlin S; Lecuyer E; Hoang T
Curr Opin Hematol; 2014 Jul; 21(4):256-64. PubMed ID: 24857885
[TBL] [Abstract][Full Text] [Related]
12. Activating mutations in protein tyrosine phosphatase Ptpn11 (Shp2) enhance reactive oxygen species production that contributes to myeloproliferative disorder.
Xu D; Zheng H; Yu WM; Qu CK
PLoS One; 2013; 8(5):e63152. PubMed ID: 23675459
[TBL] [Abstract][Full Text] [Related]
13. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.
Yang W; Wang J; Moore DC; Liang H; Dooner M; Wu Q; Terek R; Chen Q; Ehrlich MG; Quesenberry PJ; Neel BG
Nature; 2013 Jul; 499(7459):491-5. PubMed ID: 23863940
[TBL] [Abstract][Full Text] [Related]
14. A critical role for SHP2 in STAT5 activation and growth factor-mediated proliferation, survival, and differentiation of human CD34+ cells.
Li L; Modi H; McDonald T; Rossi J; Yee JK; Bhatia R
Blood; 2011 Aug; 118(6):1504-15. PubMed ID: 21670473
[TBL] [Abstract][Full Text] [Related]
15. Wild-type Kras expands and exhausts hematopoietic stem cells.
Sasine JP; Himburg HA; Termini CM; Roos M; Tran E; Zhao L; Kan J; Li M; Zhang Y; de Barros SC; Rao DS; Counter CM; Chute JP
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875320
[TBL] [Abstract][Full Text] [Related]
16. Loss of Shp2-mediated mitogen-activated protein kinase signaling in Muller glial cells results in retinal degeneration.
Cai Z; Simons DL; Fu XY; Feng GS; Wu SM; Zhang X
Mol Cell Biol; 2011 Jul; 31(14):2973-83. PubMed ID: 21576358
[TBL] [Abstract][Full Text] [Related]
17. Kras is Required for Adult Hematopoiesis.
Damnernsawad A; Kong G; Wen Z; Liu Y; Rajagopalan A; You X; Wang J; Zhou Y; Ranheim EA; Luo HR; Chang Q; Zhang J
Stem Cells; 2016 Jul; 34(7):1859-71. PubMed ID: 26972179
[TBL] [Abstract][Full Text] [Related]
18. Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells.
Akada H; Akada S; Hutchison RE; Sakamoto K; Wagner KU; Mohi G
Stem Cells; 2014 Jul; 32(7):1878-89. PubMed ID: 24677703
[TBL] [Abstract][Full Text] [Related]
19. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
[TBL] [Abstract][Full Text] [Related]
20. The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells.
Zhu HH; Feng GS
Cell Cycle; 2011 Jul; 10(14):2241-2. PubMed ID: 21701261
[No Abstract] [Full Text] [Related]
[Next] [New Search]
